Allopregnanolone Levels are Reduced in Temporal Cortex in Patients with Alzheimer’s Disease Compared to Cognitively Intact Control Subjects

BACKGROUND: The neurosteroid allopregnanolone has pronounced neuroprotective actions, increases myelination, and enhances neurogenesis. Evidence suggests that allopregnanolone dysregulation may play a role in the pathophysiology of Alzheimer’s disease (AD) and other neurodegenerative disorders. Our...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Naylor, Jennifer C., Kilts, Jason D., Hulette, Christine M., Steffens, David C., Blazer, Dan G., Ervin, John F., Strauss, Jennifer L., Allen, Trina B., Massing, Mark W., Payne, Victoria M., Youssef, Nagy A., Shampine, Lawrence J., Marx, Christine E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2907131/
https://ncbi.nlm.nih.gov/pubmed/20488256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbalip.2010.05.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados